BACKGROUND:
Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications. OBJECTIVE: To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm 3 and the implications on short-term (1-year) mortality. DESIGN: We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000-2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm 3 or an opportunistic infection at enrollment, and also evaluated trends in shortterm mortality. PARTICIPANTS: Patients establishing initial outpatient HIV treatment between 2000-2010 at an academic HIV clinic. MAIN MEASURES: The proportion of patients with a CD4 count <200 cells/mm 3 or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment. KEY RESULTS: Among 1121 patients, 41% had an initial CD4 count <200 cells/mm 3 , 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations. CONCLUSION: We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006-2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
INTRODUCTION
According to the CDC, an estimated 21% of the 1,106,400 adults and adolescents living with HIV in the United States at the end of 2006 were unaware of their infection. 1 Furthermore, an estimated 56,000 new HIV infections occur annually.
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Sequelae of undiagnosed infection are numerous, including late entry into HIV care and the consequent rapid progression to AIDS. Upwards of 39% of newly diagnosed HIV patients develop AIDS within one year of their HIV diagnosis and more than 50% of newly diagnosed patients enter care with initial CD4 counts≤200 cells/mm 3 . [3] [4] [5] [6] [7] [8] Such advanced disease in the setting of high rates of undiagnosed HIV infection has detrimental effects at both the individual and public health levels. These include HIV-associated morbidity and mortality, increased healthcare costs with advanced infection and increased transmission risk of undiagnosed infection. 9, 10 Prior to 2006, the United States Centers for Disease Control and Prevention (CDC) recommended risk-based opt-in human immunodeficiency virus (HIV) testing for the diagnosis of HIV infection. The CDC published updated HIV testing recommendations calling for routine opt-out testing in all health care settings in September 2006, in part in response to the high rates of undiagnosed HIV infection and sizeable problem of late diagnosis with advanced disease. 11 The new recommendations advocate HIV screening for all patients 13-64 years of age after informing the patients that HIV testing will be done unless refused by the patient (opt-out testing) with the goal of improving timely access to HIV prevention and treatment services as well as decreasing HIV transmission. If widely implemented, the updated CDC guidelines have the potential to foster earlier HIV diagnosis, thereby improving individual and public health outcomes.
We evaluated patients initiating outpatient HIV medical care at a dedicated HIV Clinic in the southeastern U.S. from 2000-2010 to assess trends in late diagnosis of HIV and presentation to care. We evaluated temporal trends in: 1) late presentation for outpatient HIV medical care as measured by the proportion of patients with an initial CD4 count <200 cells/mm 3 and the proportion with an opportunistic infection (OI) upon enrollment, and 2) short-term mortality (1-year) following initiation of outpatient HIV care. We hypothesized that reductions in late presentation for HIV care would be temporally related to the updated CDC testing recommendations and translate to a decrease in short-term mortality.
METHODS
Our HIV/AIDS Clinic provides comprehensive HIV services to over 1800 active patients. Our 1917 Clinic Cohort Observational Database Project is an IRB approved prospective clinical cohort study that has previously been described in detail. [12] [13] [14] Briefly, sociodemographic, psychosocial, clinical and health services utilization data are captured at the point-of-care through a locally programmed electronic medical record linked to administrative and clinical databases at our institution. The database is 100% quality controlled in real time and was recognized for excellence in information integrity. We used time series logistic regression analysis without a control group to assess temporal trends in late presentation for HIV care and short-term mortality during the observation period. We chose "calendar quarter" as a time unit for this analysis as a compromise between "month" (wide random fluctuations in outcome measures) and "year" (too few observations). To limit a priori assumptions regarding the form of the time trend and when a change in curve slope may have taken place, the calendar quarter variable was modeled using restricted cubic spline with four knots placed at percentiles 5, 35, 65 and 95, of the quarter distribution (2nd quarter 2000, 3 rd quarter 2003, 2nd quarter 2006, 3rd quarter 2008). 16 Smoothing splines are special mathematical functions that are increasingly employed as flexible tools to describe the shape of continuous exposureresponse relationships with minimal pre-specification. 17 To account for possible serial correlation among the observations, standard errors for the parameters of interest were estimated using bootstrap method (1000 replications); bias-corrected and accelerated 95% confidence intervals were also calculated. 18 We evaluated time series logistic regression models for both measures of late presentation for HIV medical care; the proportion of patients with an initial CD4 count <200 cells/ mm 3 and the proportion with an OI at clinic enrollment.
Unadjusted associations between death within one year of enrollment in outpatient HIV care and patient characteristics were assessed using simple logistic regression with particular interest in the role of initial CD4 count on short-term mortality. Finally, we evaluated time series logistic regression models of short-term mortality that adjusted for patient's baseline characteristics. The fit of adjusted models were assessed with the Hosmer-Lemeshow goodness-of-fit test, the Akaike's information criterion, and the Bayesian information criterion. All statistical models were performed using STATA.
RESULTS
Between 2000-2010, 1121 newly diagnosed patients initiated outpatient HIV care at our HIV Clinic. Of them 34.2% were white males, 42.2% were non-white males and the mean age was 36.9 years (Table 1 ) Consistent with the southeast and national HIV epidemics, racial/ethnic minority women (18.4% of the overall sample) represented a disproportionately high fraction (78%) of all women. Seventy-two percent of patients lived within the county where the clinic is located, or in one of seven adjacent counties. Sexual activity was the predominant risk factor for reported HIV transmission (MSM, 43.4%; heterosexual sex 33.3%). At enrollment, 40.9% of patients had a baseline CD4 count <200 cells/mm 3 , 34.3% had a baseline viral load >100,000 c/mL and 25% had been diagnosed with an opportunistic infection. Slightly more than 2% of the patients died within one year of their initial visit ( Table 1) Over the course of the study period, significant shifts in HIV risk factor among new patients was observed, and the mean age of new clinic patients decreased over time (Table 1) .
Initial CD4 Count at Presentation
As indicated by an initial CD4 count <200 cells/mm Table 1 ). This preliminary finding was confirmed by time series logistic regression analysis. As shown in Figure 1 , results suggested that a statistically significant downward trend (P<0.001) began in advance of the release of the revised CDC HIV testing recommendations in September 2006.
Opportunistic Infection at Presentation
As observed with the proportion of patients with an initial CD4 count <200 cells/mm 3 Table 1 ). Time series regression analysis confirmed this pattern, again suggesting that the percentage of patients presenting with an opportunistic infection started to decrease in advance of the release of the revised CDC guidelines ( Fig. 2; P<0 .001).
Early Mortality
Contingency- CI, 2.6-29.3) and baseline viral load >100,000 c/mL (OR, 3.3; 95% CI, 1.4-7.5) were most strongly associated with 1-year mortality (Data not shown). 16 To account for possible serial correlation among the observations, standard errors for the parameters of interest were estimated using bootstrap method (1000 replications);
bias-corrected and accelerated 95% confidence intervals were also calculated (dashed line).
DISCUSSION
Between 2000-2010, our clinic observed a significant decline in the proportion of patients presenting with advanced HIV infection, illustrated by dramatically fewer presentations with CD4 counts <200 cells/mm 3 and fewer patients with concomitant opportunistic infections at enrollment. Importantly, these trends appear to have translated into improved short-term survival, with significant declines observed in 1-year mortality in more recent years. Our study is among the first to evaluate temporal trends in late presentation for HIV care over the time period incorporating the updated CDC HIV testing guidelines and to further evaluate the implications for short-term mortality. Our results indicate a trend towards earlier presentation for outpatient HIV care which preceded the release of the revised HIV testing recommen- Similarly, during a subset of our study period between 2000-2005, we found that nearly one-half of our patients consistently enrolled into HIV care with CD4 counts <200 cells/mm 3 . However, between 2006-2010 a significant and clinically meaningful decline in the proportion of patients presenting with advanced immunosuppression was observed in the current study. The significant improvement in early mortality declining from 4.2% to 1.2% (death with-in 1 year of enrollment), is likely linked to earlier presentation for care, as the strongest factor associated with short-term mortality was an initial CD4 count <200 cells/mm 3 Although race was not found to be associated with early mortality in our study, a disparity in the race of the women enrolling into HIV medical care was seen consistently across our 10-year study period. A disproportionate number of non- 16 To account for possible serial correlation among the observations, standard errors for the parameters of interest were estimated using bootstrap method (1000 replications); bias-corrected and accelerated 95% confidence intervals were also calculated (dashed line). 10 The findings of our study are highly germane with regards to the recently released National HIV/AIDS Strategy for the United States. 26 Three principle tenets of that document are to: 1) reduce new HIV infections, 2) increase access to care and improve health outcomes for people living with HIV, and 3) reduce HIV-related disparities and inequities. As previously noted, trends toward earlier presentation for HIV medical care, as observed in our study, have strong potential to reduce HIV transmission and new infections. Furthermore, more timely presentation and access to HIV medical care in more recent years has been accompanied by improved short-term mortality, an important health outcome. Finally, our study highlights the continued challenge of addressing HIV-related disparities as racial-ethnic minorities continue to be over-represented among newly diagnosed patients enrolling in HIV care.
Limitations and Conclusion
The findings of our study should be interpreted with respect to the limitations in our study design. As we conducted an observational study, associations can be made but causality cannot be proven. We are able to identify significant temporal trends but cannot definitively ascribe these findings to the revised CDC testing guidelines or other factors that may have contributed. Furthermore, we conducted this study at a single site in the Southeastern United States. Therefore our findings may not be applicable to all patient populations or to other geographical regions. Furthermore, our study evaluated those patients who enrolled into care at our clinic and we are unable to account for patients who have been diagnosed but not enrolled into care in our catchment area.
In conclusion, over the time period of 2000-2010 we observed a significant decline in the proportion of patients presenting with advanced HIV infection (CD4 count <200 cells/mm 3 and/or OI at clinic enrollment). These findings have translated to a significant decline in 1-year mortality among patients establishing initial HIV care in more recent years. The improved timeliness of HIV diagnosis and linkage to care has clear implications for individual patients and the public health, meriting further evaluation in larger patient populations.
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